Persistent disabling breathlessness in chronic obstructive pulmonary disease

International Journal of COPD

Volumn 11, Issue 1, 2016, Pages 2805-2812

  Sundh, Josefin ^a   Ekström, Magnus ^b  

^a ÖREBRO UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Breathlessness; COPD; Dyspnea; Longitudinal analysis; Risk factors; Treatment

Indexed keywords

AGE; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE EXACERBATION; DYSPNEA; FEMALE; FOLLOW UP; HEART FAILURE; HUMAN; ISCHEMIC HEART DISEASE; LONGITUDINAL STUDY; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; OBESITY; PERSISTENT DISABLING BREATHLESSNESS; PREVALENCE; RESPIRATORY FAILURE; RISK FACTOR; DISABILITY; FORCED EXPIRATORY VOLUME; HEALTH STATUS; LUNG; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PATHOPHYSIOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REGISTER; STATISTICAL MODEL; SWEDEN; TIME FACTOR; TREATMENT OUTCOME; VITAL CAPACITY;

AGED; DISABILITY EVALUATION; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH STATUS; HUMANS; LOGISTIC MODELS; LONGITUDINAL STUDIES; LUNG; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REGISTRIES; RISK FACTORS; SWEDEN; TIME FACTORS; TREATMENT OUTCOME; VITAL CAPACITY;

EID: 84995662757     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S119992     Document Type: Article

References (36)

1. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Available from: http://www.goldcopd.com. Accessed June 14, 2016.
2. Miravitlles M, Ferrer J, Baro E, Lleonart M, Galera J. Differences between physician and patient in the perception of symptoms and their severity in COPD. Respir Med. 2013;107(12):1977-1985.
3. Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. Chest. 1988;93(3):580-586.
4. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581-586.
5. Wilke S, Jones PW, Mullerova H, et al. One-year change in health status and subsequent outcomes in COPD. Thorax. 2015;70(5):420-425.
6. Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest. 2002;121(5):1434-1440.
7. Casanova C, Marin JM, Martinez-Gonzalez C, et al. Differential effect of modified Medical Research Council Dyspnea, COPD Assessment Test, and Clinical COPD Questionnaire for symptoms evaluation within the new GOLD staging and mortality in COPD. Chest. 2015;148(1):159-168.
8. Parshall MB, Schwartzstein RM, Adams L, et al. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med. 2012;185(4):435-452.
9. Johnson MJ, Currow DC. Chronic refractory breathlessness is a distinct clinical syndrome. Curr Opin Support Palliat Care. 2015;9(3):203-205.
10. Henoch I, Strang S, Löfdahl C-G, Ekberg-Janssn A. Health-related quality of life in a nationwide cohort of patients with COPD related to other characteristics. Eur Clin Respir J. 2016;3:31459.
11. Luftvägsregistret, Årsrapport 2015 [Swedish National Register of COPD, Annual report 2015]. Available from: http://www.registercentrum.se/sites/default/files/dokument/luftvagsregistret_arsrapport_2015.pdf. Accessed October 30, 2016.
12. Backman H, Eriksson B, Ronmark E, et al. Decreased prevalence of moderate to severe COPD over 15 years in northern Sweden. Respir Med. 2016;114:103-110.
13. Qaseem A, Wilt TJ, Weinberger SE, et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med. 2011;155(3):179-191.
14. Punekar YS MH, Small M, Holbrook T, Wood R, Naya I, Valle M. Prevalence and burden of dyspnoea among patients with chronic obstructive pulmonary disease in five European countries. Pulm Ther. 2016;2:59-72.
15. Mullerova H, Lu C, Li H, Tabberer M. Prevalence and burden of breathlessness in patients with chronic obstructive pulmonary disease managed in primary care. PloS One. 2014;9(1):e85540.
16. Perez T, Burgel PR, Paillasseur JL, et al. Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2015;10:1663-1672.
17. Katsura H, Yamada K, Kida K. Both generic and disease specific health-related quality of life are deteriorated in patients with underweight COPD. Respir Med. 2005;99(5):624-630.
18. Sahebjami H, Sathianpitayakul E. Influence of body weight on the severity of dyspnea in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;161(3 Pt 1):886-890.
19. Launois C, Barbe C, Bertin E, et al. The modified Medical Research Council scale for the assessment of dyspnea in daily living in obesity: a pilot study. BMC Pulm Med. 2012;12:61.
20. Garcia-Rio F, Soriano JB, Miravitlles M, et al. Impact of obesity on the clinical profile of a population-based sample with chronic obstructive pulmonary disease. PloS One. 2014;9(8):e105220.
21. Neuman A, Gunnbjornsdottir M, Tunsater A, et al. Dyspnea in relation to symptoms of anxiety and depression: a prospective population study. Respir Medicine. 2006;100(10):1843-1849.
22. Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T, Mishima M. Longitudinal deteriorations in patient reported outcomes in patients with COPD. Respir Med. 2007;101(1):146-153.
23. Oga T, Tsukino M, Hajiro T, Ikeda A, Nishimura K. Analysis of longitudinal changes in dyspnea of patients with chronic obstructive pulmonary disease: an observational study. Respir Res. 2012;13(1):85.
24. Currow DC, Abernethy AP, Allcroft P, et al. The need to research refractory breathlessness. Eur Respir J. 2016;47(1):342-343.
25. Currow DC, Johnson MJ. Chronic breathlessness: silent and deadly. Curr Opin Support Palliat Care. 2016;10(3):221-222.
26. Karner C, Chong J, Poole P. Tiotropium versus placebo for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2014;7:CD009285.
27. Kew KM, Mavergames C, Walters JA. Long-acting beta2-agonists for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2013;10:CD010177.
28. McCarthy B, Casey D, Devane D, Murphy K, Murphy E, Lacasse Y. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2015;2:CD003793.
29. Cabrera C, Casanova C, Martin Y, et al. Agreement between a simple dyspnea-guided treatment algorithm for stable COPD and the GOLD guidelines: a pilot study. Int J Chron Obstruct Pulmon Dis. 2016;11:1217-1222.
30. Lopez-Campos JL, Abad Arranz M, Calero Acuna C, et al. Determinants for changing the treatment of COPD: a regression analysis from a clinical audit. Int J Chron Obstruct Pulmon Dis. 2016;11:1171-1178.
31. Jones RC, Price D, Chavaness NH, et al. Multi-component assessment of chronic obstructive pulmonary disease: an evaluation of the ADO and DOSE indices and the global obstructive lung disease categories in international primary care data sets. NPJ Prim Care Respir Med. 2016;26:16010.
32. Stallberg B, Janson C, Johansson G, et al. Management, morbidity and mortality of COPD during an 11-year period: an observational retrospective epidemiological register study in Sweden (PATHOS). Prim Care Respir J. 2014;23(1):38-45.
33. Sundh J, Johansson G, Larsson K, et al. Comorbidity and health-related quality of life in patients with severe chronic obstructive pulmonary disease attending Swedish secondary care units. Int J Chron Obstruct Pulmon Dis. 2015;10:173-183.
34. Sundh J, Stallberg B, Lisspers K, Kampe M, Janson C, Montgomery S. Comparison of the COPD Assessment Test (CAT) and the Clinical COPD Questionnaire (CCQ) in a clinical population. COPD. 2015:1-9.
35. Ekstrom M, Nilsson F, Abernethy AA, Currow DC. Effects of opioids on breathlessness and exercise capacity in chronic obstructive pulmonary disease. A systematic review. Ann Am Thorac Soc. 2015;12(7):1079-1092.
36. Simon ST, Higginson IJ, Booth S, Harding R, Bausewein C. Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults. Cochrane Database System Rev. 2010 (1):CD007354.